1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
MedTech Venture Prototyping Fund is sponsored by NYU Technology Opportunities & Ventures (TOV). The MedTech Venture Prototyping Fund supports prototype development and evaluation of medical device and digital health technologies developed at NYU. The fund aims to encourage the advancement of innovations that have near-term potential for licensing and commercialization.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
MedTech Venture Prototyping - Technology Opportunities & Ventures by NYU and NYU Langone Health MedTech Venture Prototyping Fund (MVP Fund) An intramural funding opportunity that supports the advancement of medical device and digital health technologies.
MedTech Venture Prototyping Commercialization Process Intellectual Property 101 NYU Innovators’ “Bill of Rights” Therapeutics Alliances (Innovators) Therapeutics Alliances Request for Proposals MedTech Venture Prototyping Technology Acceleration & Commercialization Awards NYU Langone Health Venture Fund Biomedical Entrepreneurship Program Biomedical Entrepreneurship Program Courses NYU MedTech Venture Prototyping Fund is an intramural funding opportunity designed to encourage and promote the advancement of medical devices, diagnostic, and digital health technologies owned by NYU that have the potential for commercialization, through prototype development and evaluation.
Projects that involve NYU technologies that have already been licensed to a commercial entity will not be considered. Track 1: Accelerated Commercialization Proposals Track 1 proposals support technologies in advanced stages of development, aiming to achieve significant milestones closer to commercialization.
Applicants may request up to a maximum budget of $75,000, which may include costs for materials, salaries (non-PI) and contracted third-party services. As an internal funding opportunity, there will be no indirect costs charged. Please note that principal investigator salaries are not permitted.
Project plans may include costs of external consultants or companies to supplement existing expertise. Track 2: Early Concept and Prototyping Proposals Track 2 proposals should focus on the early prototype or proof-of-concept stage to validate feasibility and potential market value. These proposals may be based on ideas in the conceptual stage, such as a conceptual “napkin sketch.
” Proposed work should demonstrate the potential for addressing unmet needs in the market. Applicants may request up to a maximum budget of $25,000 with no indirect costs charged, which may include costs for materials and contracted third-party services. Please note that salaries are not supported under this track.
Application Deadline: June 26, 2026 Funding Start Date: September 1, 2026 Funding End Date: August 31, 2027 Principal Investigators (PIs) applying must meet the following criteria: Primary Appointment: Must hold a primary appointment at the School of Medicine. Technology Ownership: Projects must involve NYU-owned technologies that are NOT currently licensed to commercial partners.
An investigator may submit a one-page proposal via email to MVPFund@ nyulangone. org by June 26, 2026. Your email subject line must be read: “MedTech Venture Prototyping Fund Proposal- Track [].
” Shortlisted Track 1 applications may be invited to submit a detailed proposal or give a presentation. Required Proposal Components: Provide a description of the innovation, emphasizing how it works, its novelty, and competitive advantages compared to current approaches.
Explain the unmet need that your technology addresses, this can include details of the market size, adoption costs, and any supporting data that highlights why this innovation is important. Describe the current stage of development, including how the proposed work will carry the technology forward towards commercialization. Focus on how these efforts will transform the target market or create impactful solutions.
Prototype Development Plan Outline milestones for prototype creation and evaluation, and detail how the commercialization plan will attract follow-up support. Present a detailed breakdown of fund allocation and justification.
NOTE: For undisclosed technologies, please complete an innovation disclosure form before applying The Technology Opportunities & Ventures (TOV) office will assist in selecting and managing any external contractors required for project execution. TOV can also provide support in identifying and engaging with external contractors for work such as prototype design and development, animal studies, and other specialized research activities.
For questions about the MedTech Venture Prototyping Fund, please contact MVPFund@nyulangone. org
According to the current listing, eligibility includes: NYU innovators developing medical device and digital health technologies. Confirm the full requirements in the official notice before applying.
MedTech Venture Prototyping Fund is funded by NYU Technology Opportunities & Ventures (TOV). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleAt CGI on September 23, 2026, Global Impact Ventures committed $100 million over three years across economic opportunity, health, education, climate resilience and humanitarian needs. There is no application portal. The access route is the intermediary infrastructure — fiscal sponsorship, grantmaking administration, and a 250-organization network.
Read articleThe Hewlett Foundation's Emerging Technology and Security Initiative commits $20 million a year through 2031 across AI, biotechnology, and quantum computing security. Its 2026 exploratory grants went to thirteen named institutions with no open call. For organizations outside that list, the path in runs through a specific set of moves — and the five-year term starting in 2027 is the window.
Read article